Arkadios Wealth Advisors Merck & Co., Inc. Transaction History

Arkadios Wealth Advisors

$1.71 Billion
Q4 2024

A detailed history of Arkadios Wealth Advisors transactions in Merck & Co., Inc. stock. As of the latest transaction made, Arkadios Wealth Advisors holds 36,591 shares of MRK stock, worth $3.5 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

36,591

Previous 42,609 14.12%

Holding current value

$3.5 Million

Previous $4.84 Million 24.76%

% of portfolio

0.21%

Previous 0.29%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 15, 2025	SELL	$96.31 - $114.76 $579,593 - $690,625	-6,018 Reduced 14.12%	36,591 $3.64 Million
Q3 2024 Oct 24, 2024	BUY	$111.15 - $128.97 $84,140 - $97,630	757 Added 1.81%	42,609 $4.84 Million
Q2 2024 Jul 29, 2024	BUY	$123.8 - $132.96 $1.25 Million - $1.34 Million	10,057 Added 31.63%	41,852 $5.18 Million
Q1 2024 Apr 30, 2024	BUY	$113.24 - $131.95 $707,750 - $824,687	6,250 Added 24.47%	31,795 $4.2 Million
Q4 2023 Jan 24, 2024	SELL	$100.18 - $109.02 $225,705 - $245,622	-2,253 Reduced 8.1%	25,545 $2.78 Million
Q3 2023 Oct 13, 2023	BUY	$102.95 - $114.33 $1.1 Million - $1.22 Million	10,714 Added 62.71%	27,798 $2.86 Million
Q2 2023 Jul 26, 2023	BUY	$108.61 - $118.38 $4,453 - $4,853	41 Added 0.24%	17,084 $1.97 Million
Q1 2023 May 02, 2023	SELL	$102.94 - $114.86 $22,440 - $25,039	-218 Reduced 1.26%	17,043 $1.81 Million
Q4 2022 Jan 11, 2023	BUY	$87.44 - $112.11 $26,581 - $34,081	304 Added 1.79%	17,261 $0
Q3 2022 Oct 21, 2022	BUY	$84.53 - $94.96 $125,273 - $140,730	1,482 Added 9.58%	16,957 $1.46 Million
Q2 2022 Jul 14, 2022	BUY	$83.49 - $94.64 $102,943 - $116,691	1,233 Added 8.66%	15,475 $1.41 Million
Q1 2022 May 02, 2022	BUY	$73.51 - $82.4 $367 - $412	5 Added 0.04%	14,242 $1.17 Million
Q4 2021 Feb 03, 2022	SELL	$72.28 - $90.54 $100,830 - $126,303	-1,395 Reduced 8.92%	14,237 $1.09 Million
Q3 2021 Oct 19, 2021	SELL	$71.68 - $78.83 $122,071 - $134,247	-1,703 Reduced 9.82%	15,632 $1.17 Million
Q2 2021 Jul 28, 2021	BUY	$70.31 - $77.77 $353,026 - $390,483	5,021 Added 40.77%	17,335 $1.35 Million
Q1 2021 Apr 26, 2021	BUY	$68.86 - $81.11 $176,350 - $207,722	2,561 Added 26.26%	12,314 $949,000
Q4 2020 Feb 09, 2021	BUY	$71.77 - $79.65 $248,180 - $275,429	3,458 Added 54.93%	9,753 $797,000
Q3 2020 Nov 10, 2020	BUY	$73.18 - $82.95 $3,146 - $3,566	43 Added 0.69%	6,295 $503 Million
Q2 2020 Aug 10, 2020	BUY	$70.42 - $80.13 $64,293 - $73,158	913 Added 17.1%	6,252 $489 Million
Q1 2020 May 14, 2020	BUY	$63.36 - $87.82 $31,046 - $43,031	490 Added 10.11%	5,339 $411 Million
Q4 2019 Feb 14, 2020	BUY	$77.58 - $87.54 $376,185 - $424,481	4,849 New	4,849 $420,000

Others Institutions Holding MRK

# of Institutions

3,820

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $242B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arkadios Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Arkadios Wealth Advisors with notifications on news.

Account

Arkadios Wealth Advisors Merck & Co., Inc. Transaction History